Last Updated on December 31, 2023 by The Health Master
A new rule in January classifying medical devices such as nebulisers, blood-pressure monitors, digital thermometers and glucometers as drugs is causing a short supply of these products, their manufacturers and suppliers said.
These devices are widely used in the home treatment of C-19 patients and are facing high demand amid the second wave of the pandemic sweeping across the country.
Also read:
For more details on licensing process of Medical devices, click here
For notifications of Medical Devices, click here
But companies dealing in these said they are facing hurdles in scaling up production, import and retail of the products as every process now needs government approval and licenses under the Drugs Act.
Ecommerce companies said there are fewer sellers of these devices on their platforms compared with last year.
The government hasn’t put oxygen concentrators under the Drugs Act yet — these portable machines to produce oxygen can be sold under voluntary license registration till September.
But manufacturers and sellers are already facing harassment from drug inspectors, who ask them to take government approvals and follow the drug rules, two senior industry executives said.
Also read:
Remdesivir, Tocilizumab no wonder drugs: PGI Doctor
Two Doctors among five arrested for Remdesivir black marketing
Zydus gets final USFDA nod for Propafenone HCL ER capsules
Alembic gets USFDA nod for depression treatment drug
Black marketing of Remdesivir: 4 pharmacists arrested
Nutraceuticals for mental well-being
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
